ARTICLE SUMMARY:
Filling the treatment gap for Class III heart failure patients is a huge challenge, but also a huge potential opportunity for device manufacturers. One company hoping to tap the wellspring is Sunshine Heart, a first-mover in the market for earlier-stage cardiac assist devices. As the lone clinical pioneer in this space, the company has faced substantial hurdles, but now sees positive momentum on its side.
The large and underserved heart failure (HF) space presents a tremendous opportunity for high-tech device solutions; however, it has historically been a tough market for device companies to penetrate.
